Cornerstone Medical Associates, Inc.
$43.5K 311 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Valneva Usa, Inc.
Valneva Usa, Inc. reported $43,536.30 across General Payments, Research, and Ownership to 67 physicians and teaching hospitals across 67 transactions.
- $43.5K Below-median payer
- All-tracks total
- 67 Below-median volume
- Transactions
- 67 Below-median reach
- Recipients
- −$50.5K
- General Payments vs PY2023
Valneva Usa, Inc. reported $43,536.30 across all CMS Open Payments tracks (General + Research + Ownership) to 67 physicians and teaching hospitals in Program Year 2024 - ranking #1387 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $43,536.30, averaging $649.80 per recipient.
How Valneva Usa, Inc.'s $43.5K all-tracks total breaks down
Valneva Usa, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer valneva-usa-inc Valneva Usa, Inc.
$43.5K · #1387/1,925 · 0.0% industry · PY2024
- TOT $43.5K
- RANK #1387
- SHARE 0.0%
- TXN 67
- RCP 67
- CAT 3
- GEN $43.5K
- ΔGEN −$50.5K
- TOP1 20.7%
- PY 2024
Volume peers
Nearest volume peer: Cornerstone Medical Associates, Inc. ($43.5K)
Valneva Usa, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Valneva Usa, Inc.'s CMS-reported General Payments decreased by $50.5K (−53.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VALNEVA USA, INC.PY2023: VALNEVA USA, INC.PY2024: Valneva Usa, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $94,042.82
- PY2024
- $43,536.30
What the Data Shows for Valneva Usa, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Valneva Usa, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $41.4K, accounting for 95.1% of this company's General Payments and 24 transactions.
General Payment Breakdown by Type
Across 3 types of general payments, Valneva Usa, Inc.'s largest category was "Consulting Fee" at $41.4K - 95.1% of General Payments.
How Valneva Usa, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $41.4K | 24 | 95.1% |
| Food and Beverage | $2.0K | 39 | 4.7% |
| Travel and Lodging | $105.00 | 4 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $30,412.45 (69.9%) of $43,536.30 in this company's General Payments records across 38 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Valneva Usa, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Bradley Connor
$9,000.00 across 1 reported transactions
- 2
Fernando Ysern Borras
$6,429.99 across 5 reported transactions
- 3
Lin Chen
$6,313.26 across 9 reported transactions
- 4
Ines Esquilin
$4,949.99 across 4 reported transactions
- 5
Davidson Hamer
$3,719.21 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Valneva Usa, Inc. ranks #1387 of 1,925 by total payments (bottom 28% by spend) but is notably more concentrated than that alone would suggest -- #958 of 1,838 by HHI (bottom 48% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Novastep Inc. : $391.6K total payments, HHI 1187
- Amylyx Pharmaceuticals, Inc. : $70.8K total payments, HHI 1184
- Zavation Medical Products, LLC : $696.6K total payments, HHI 1183
- Topcon Healthcare, Inc. : $675.4K total payments, HHI 1183
- MicroPort Orthopedics Inc : $2.8M total payments, HHI 1182
- Fuse Medical, Inc. : $236.2K total payments, HHI 1179
- Valneva Usa, Inc. (this company) : $43.5K total payments, HHI 1173
- Bracco Diagnostics Inc. : $410.3K total payments, HHI 1171
- Instylla, Inc. : $144.2K total payments, HHI 1169
- Reprise Biomedical, Inc. : $117.0K total payments, HHI 1168
- DentalEZ Alabama, Inc. : $5.9K total payments, HHI 1168
- Hollister Incorporated : $45.3K total payments, HHI 1167
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Valneva Usa, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Valneva Usa, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Valneva Usa, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Oticon Medical, LLC
$43.5K 159 recipients
Compare payment profiles
OrphAI Therapeutics Inc.
$43.7K 5 recipients
Compare payment profiles
Zap Surgical Systems, Inc.
$43.0K 105 recipients
Compare payment profiles
TrackX Technology, Inc.
$44.2K 131 recipients
Compare payment profiles
Smoky Mountain Surgical Llc
$42.8K 431 recipients
Compare payment profiles
Put this to use
Valneva Usa, Inc. ranks #1387 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Valneva Usa, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.